Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems makes an implanted nerve stimulation device that treats moderate to severe obstructive sleep apnea. It last closed at $59.43 on Nov 17, up 0.56% on the day. INSP reports earnings on Wed, Feb 10, 2027. The average 12-month price target from 10 analysts is $72.70 (+22.3% from the last close), with a high of $93.00 and a low of $60.00. Analyst consensus is Hold, based on the latest ratings from 10 firms (2 buy, 7 hold, 1 sell). In the past 30 days there were 1 dark pool print totaling $554K, the largest $554K.
Key Stats
Last 12 monthsNot reported for this period.
From INSP's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 2). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 10 analysts who set a price target on INSP in the past 90 days. The average target is $72.70, with a high of $93.00 and a low of $60.00, compared with the last close of $59.43.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 13 | Freedom Capital Markets | Target lowered | Buy | $97 → $93 |
| Nov 3 | JP Morgan | Target raised | Hold | $60 → $65 |
| Nov 3 | Truist Securities | Target lowered | Hold | $78 → $76 |
| Nov 3 | Wells Fargo | Maintained | Hold | $69 |
| Nov 3 | Evercore ISI Group | Target raised | Hold | $54 → $60 |
Technical Analysis
The stock is 11% below its 20 day and 16% below its 50 day average. It is 4% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot at $58.89, and the nearest resistance the Pivot R1 at $59.99.
| RSI (14) | 34.39 | Weak, oversold below 30 | Neutral |
| MACD | -2.46 | Below its signal line | Bearish |
| Stochastic | 7.4 | Near the bottom of its range | Oversold |
| ADX (14) | 28.7 | Trending down | |
| Williams %R | -88.4 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -122.3 | Oversold below −100, overbought above 100 | Oversold |
| Rate of change | −3.8% | Change over 10 sessions | Bearish |
| ATR (14) | $2.77 | Typical daily range, 4.7% of price |
| RSI (14) | 45.53 | Middle of its range | Neutral |
| MACD | 1.26 | Below its signal line | Bearish |
| Stochastic | 29.3 | Middle of its range | Neutral |
| ADX (14) | 21.5 | Weak trend | |
| Williams %R | -82.9 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -33.1 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −18.6% | Change over 10 sessions | Bearish |
| ATR (14) | $6.68 | Typical daily range, 11.2% of price |
What happened before
See how INSP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How INSP has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
Whale Options Flow
90DNo whale options trades in INSP in the last 90 days.
Dark Pool
30DINSP Institutional Ownership
Full report →- ●158 buying vs 148 selling
- ▼Held by funds -10.8 pts
- ▲Funds holding +34
- ▲Superinvestors: 3 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 309 | 275 | +12.4% |
| In funds' top 10 | 1 | 1 | 0.0% |
| Held by funds | 120.9% | 131.7% | −10.8 pts |
| New / increased | 81 / 77 | 64 / 97 | −1.9% |
| Reduced / sold out | 104 / 44 | 75 / 91 | −10.8% |
| Put/call ratio | 0.41 | 0.00 | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INSP is in one of them and how their past INSP trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered INSP in an article yet. Here's the latest on the wider market.
INSP Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Sell | $1K – $15K | Jul 29, 2026 | Sep 22, 2026 | 55 d |
| Donald J TrumpExecutive branch | Buy | $15K – $50K | Jul 8, 2026 | Sep 22, 2026 | 76 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 15, 2026 | Jul 1, 2026 | 47 d |
| Bryan BedfordExecutive branch | Sell | $1K – $15K | Sep 10, 2025 | Dec 19, 2025 | 100 d |
| Dan GoldmanD · NY | Sell | $1K – $15K | Apr 10, 2023 | May 19, 2023 | 39 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Inspire Medical Systems
Inspire Medical Systems is a medical technology company based in Golden Valley, Minnesota, focused on treating obstructive sleep apnea. Its main product is the Inspire system, an implanted device that gently stimulates a nerve to keep the airway open during sleep, for patients with moderate to severe sleep apnea who cannot tolerate CPAP. The company sells the system mainly to hospitals and ambulatory surgery centers in the United States, with additional sales in select European countries, Japan and Singapore, and works closely with ENT physicians and sleep centers.
- Headquarters
- Golden Valley, MN
- Founded
- 2007
- Website
- inspiresleep.com ↗






